Health X Platform Ltd (NSE: HEALTHX.NS) Stock Competitors & Peer Comparison
See HEALTHX.NS's competitors and their performance on the NSE and across the wider stock market.
Peer Comparison Table: Specialty Retail Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HEALTHX.NS and its NSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HEALTHX.NS | ₹300.00 | +0.00% | 9.5B | 810.81 | ₹0.37 | N/A |
| ZOMATO.NS | ₹215.19 | +0.00% | 2T | 286.92 | ₹0.75 | N/A |
| ZOMATO.BO | ₹215.25 | +0.00% | 2T | 377.63 | ₹0.57 | N/A |
| MEESHO.NS | ₹214.44 | +3.44% | 991.2B | -156.53 | -₹1.37 | N/A |
| NYKAA.NS | ₹332.15 | +2.59% | 951.2B | 357.61 | ₹0.93 | N/A |
| NYKAA.BO | ₹326.00 | +0.74% | 923.2B | 326.00 | ₹1.00 | N/A |
| LALITHAA.NS | ₹304.90 | +4.99% | 170.7B | 16.90 | ₹18.04 | N/A |
| LALITHAA.BO | ₹304.80 | +4.99% | 170.6B | 16.90 | ₹18.04 | N/A |
| INDIAMART.NS | ₹1,646.30 | -0.99% | 99B | 20.90 | ₹78.77 | +3.64% |
| INDIAMART.BO | ₹1,643.15 | -1.20% | 98.9B | 20.82 | ₹78.93 | +3.64% |
Stock Comparison
Zomato Limited (NSE: ZOMATO.NS)
HEALTHX.NS vs ZOMATO.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, ZOMATO.NS has a market cap of 2T. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while ZOMATO.NS trades at ₹215.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas ZOMATO.NS's P/E ratio is 286.92. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to ZOMATO.NS's ROE of +0.02%. Regarding short-term risk, HEALTHX.NS is more volatile compared to ZOMATO.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check ZOMATO.NS's competition here
Zomato Limited (BSE: ZOMATO.BO)
HEALTHX.NS vs ZOMATO.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, ZOMATO.BO has a market cap of 2T. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while ZOMATO.BO trades at ₹215.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas ZOMATO.BO's P/E ratio is 377.63. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to ZOMATO.BO's ROE of +0.02%. Regarding short-term risk, HEALTHX.NS is more volatile compared to ZOMATO.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check ZOMATO.BO's competition here
Meesho Ltd. (NSE: MEESHO.NS)
HEALTHX.NS vs MEESHO.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, MEESHO.NS has a market cap of 991.2B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while MEESHO.NS trades at ₹214.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas MEESHO.NS's P/E ratio is -156.53. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to MEESHO.NS's ROE of N/A. Regarding short-term risk, HEALTHX.NS is more volatile compared to MEESHO.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check MEESHO.NS's competition here
FSN E-Commerce Ventures Limited (NSE: NYKAA.NS)
HEALTHX.NS vs NYKAA.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, NYKAA.NS has a market cap of 951.2B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while NYKAA.NS trades at ₹332.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas NYKAA.NS's P/E ratio is 357.61. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to NYKAA.NS's ROE of +0.18%. Regarding short-term risk, HEALTHX.NS is more volatile compared to NYKAA.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check NYKAA.NS's competition here
Fsn E-commerce Ventures Ltd. (BSE: NYKAA.BO)
HEALTHX.NS vs NYKAA.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, NYKAA.BO has a market cap of 923.2B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while NYKAA.BO trades at ₹326.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas NYKAA.BO's P/E ratio is 326.00. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to NYKAA.BO's ROE of +0.18%. Regarding short-term risk, HEALTHX.NS is more volatile compared to NYKAA.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check NYKAA.BO's competition here
Lalithaa Jewellery Mart Limited (NSE: LALITHAA.NS)
HEALTHX.NS vs LALITHAA.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, LALITHAA.NS has a market cap of 170.7B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while LALITHAA.NS trades at ₹304.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas LALITHAA.NS's P/E ratio is 16.90. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to LALITHAA.NS's ROE of N/A. Regarding short-term risk, HEALTHX.NS is less volatile compared to LALITHAA.NS. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check LALITHAA.NS's competition here
Lalithaa Jewellery Mart Limited (BSE: LALITHAA.BO)
HEALTHX.NS vs LALITHAA.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, LALITHAA.BO has a market cap of 170.6B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while LALITHAA.BO trades at ₹304.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas LALITHAA.BO's P/E ratio is 16.90. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to LALITHAA.BO's ROE of N/A. Regarding short-term risk, HEALTHX.NS is less volatile compared to LALITHAA.BO. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check LALITHAA.BO's competition here
IndiaMART InterMESH Limited (NSE: INDIAMART.NS)
HEALTHX.NS vs INDIAMART.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, INDIAMART.NS has a market cap of 99B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while INDIAMART.NS trades at ₹1,646.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas INDIAMART.NS's P/E ratio is 20.90. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to INDIAMART.NS's ROE of +0.22%. Regarding short-term risk, HEALTHX.NS is more volatile compared to INDIAMART.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check INDIAMART.NS's competition here
IndiaMART InterMESH Limited (BSE: INDIAMART.BO)
HEALTHX.NS vs INDIAMART.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, INDIAMART.BO has a market cap of 98.9B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while INDIAMART.BO trades at ₹1,643.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas INDIAMART.BO's P/E ratio is 20.82. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to INDIAMART.BO's ROE of +0.22%. Regarding short-term risk, HEALTHX.NS is more volatile compared to INDIAMART.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check INDIAMART.BO's competition here
Brainbees Solutions Limited (NSE: FIRSTCRY.NS)
HEALTHX.NS vs FIRSTCRY.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, FIRSTCRY.NS has a market cap of 89.9B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while FIRSTCRY.NS trades at ₹172.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas FIRSTCRY.NS's P/E ratio is -59.36. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to FIRSTCRY.NS's ROE of N/A. Regarding short-term risk, HEALTHX.NS is more volatile compared to FIRSTCRY.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check FIRSTCRY.NS's competition here
Brainbees Solutions Limited (BSE: FIRSTCRY.BO)
HEALTHX.NS vs FIRSTCRY.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, FIRSTCRY.BO has a market cap of 89.9B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while FIRSTCRY.BO trades at ₹172.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas FIRSTCRY.BO's P/E ratio is -59.36. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to FIRSTCRY.BO's ROE of N/A. Regarding short-term risk, HEALTHX.NS is more volatile compared to FIRSTCRY.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check FIRSTCRY.BO's competition here
Aditya Vision Ltd. (BSE: AVL.BO)
HEALTHX.NS vs AVL.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, AVL.BO has a market cap of 82.3B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while AVL.BO trades at ₹637.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas AVL.BO's P/E ratio is 58.45. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to AVL.BO's ROE of +0.21%. Regarding short-term risk, HEALTHX.NS is more volatile compared to AVL.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check AVL.BO's competition here
Aditya Vision Ltd. (NSE: AVL.NS)
HEALTHX.NS vs AVL.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, AVL.NS has a market cap of 82.3B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while AVL.NS trades at ₹636.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas AVL.NS's P/E ratio is 58.54. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to AVL.NS's ROE of +0.22%. Regarding short-term risk, HEALTHX.NS is more volatile compared to AVL.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check AVL.NS's competition here
Electronics Mart India Limited (NSE: EMIL.NS)
HEALTHX.NS vs EMIL.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, EMIL.NS has a market cap of 75.5B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while EMIL.NS trades at ₹196.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas EMIL.NS's P/E ratio is 38.11. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to EMIL.NS's ROE of +0.13%. Regarding short-term risk, HEALTHX.NS is less volatile compared to EMIL.NS. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check EMIL.NS's competition here
Electronics Mart India Limited (BSE: EMIL.BO)
HEALTHX.NS vs EMIL.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, EMIL.BO has a market cap of 75.4B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while EMIL.BO trades at ₹196.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas EMIL.BO's P/E ratio is 36.55. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to EMIL.BO's ROE of +0.13%. Regarding short-term risk, HEALTHX.NS is less volatile compared to EMIL.BO. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check EMIL.BO's competition here
Augmont Enterprises Limited (NSE: AUGMONT.NS)
HEALTHX.NS vs AUGMONT.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, AUGMONT.NS has a market cap of 73B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while AUGMONT.NS trades at ₹874.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas AUGMONT.NS's P/E ratio is 22.92. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to AUGMONT.NS's ROE of +0.53%. Regarding short-term risk, HEALTHX.NS is less volatile compared to AUGMONT.NS. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check AUGMONT.NS's competition here
RattanIndia Enterprises Limited (NSE: RTNINDIA.NS)
HEALTHX.NS vs RTNINDIA.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, RTNINDIA.NS has a market cap of 36.6B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while RTNINDIA.NS trades at ₹26.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas RTNINDIA.NS's P/E ratio is -16.59. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to RTNINDIA.NS's ROE of -0.72%. Regarding short-term risk, HEALTHX.NS is more volatile compared to RTNINDIA.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check RTNINDIA.NS's competition here
Rattanindia Enterprises Limited (BSE: RTNINDIA.BO)
HEALTHX.NS vs RTNINDIA.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, RTNINDIA.BO has a market cap of 36.6B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while RTNINDIA.BO trades at ₹26.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas RTNINDIA.BO's P/E ratio is -16.59. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to RTNINDIA.BO's ROE of -0.72%. Regarding short-term risk, HEALTHX.NS is more volatile compared to RTNINDIA.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check RTNINDIA.BO's competition here
Panorama Studios International (BSE: PANORAMA.BO)
HEALTHX.NS vs PANORAMA.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, PANORAMA.BO has a market cap of 13.9B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while PANORAMA.BO trades at ₹53.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas PANORAMA.BO's P/E ratio is 19.56. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to PANORAMA.BO's ROE of +0.12%. Regarding short-term risk, HEALTHX.NS is more volatile compared to PANORAMA.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check PANORAMA.BO's competition here
Manoj Vaibhav Gems 'N' Jewellers Limited (BSE: MVGJL.BO)
HEALTHX.NS vs MVGJL.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, MVGJL.BO has a market cap of 10.5B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while MVGJL.BO trades at ₹215.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas MVGJL.BO's P/E ratio is 55.48. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to MVGJL.BO's ROE of +0.15%. Regarding short-term risk, HEALTHX.NS is more volatile compared to MVGJL.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check MVGJL.BO's competition here
Manoj Vaibhav Gems 'N' Jewellers Limited (NSE: MVGJL.NS)
HEALTHX.NS vs MVGJL.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, MVGJL.NS has a market cap of 10.5B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while MVGJL.NS trades at ₹214.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas MVGJL.NS's P/E ratio is 9.12. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to MVGJL.NS's ROE of +0.15%. Regarding short-term risk, HEALTHX.NS is more volatile compared to MVGJL.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check MVGJL.NS's competition here
Health X Platform Limited (BSE: SASTASUNDR.BO)
HEALTHX.NS vs SASTASUNDR.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, SASTASUNDR.BO has a market cap of 9.8B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while SASTASUNDR.BO trades at ₹307.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas SASTASUNDR.BO's P/E ratio is 37.49. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to SASTASUNDR.BO's ROE of +0.00%. Regarding short-term risk, HEALTHX.NS is more volatile compared to SASTASUNDR.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check SASTASUNDR.BO's competition here
Health X Platform Ltd (BSE: HEALTHX.BO)
HEALTHX.NS vs HEALTHX.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, HEALTHX.BO has a market cap of 9.3B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while HEALTHX.BO trades at ₹293.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas HEALTHX.BO's P/E ratio is 792.84. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to HEALTHX.BO's ROE of +0.00%. Regarding short-term risk, HEALTHX.NS is more volatile compared to HEALTHX.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check HEALTHX.BO's competition here
Vasa Denticity Ltd. (NSE: DENTALKART.NS)
HEALTHX.NS vs DENTALKART.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, DENTALKART.NS has a market cap of 6.7B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while DENTALKART.NS trades at ₹420.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas DENTALKART.NS's P/E ratio is 40.11. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to DENTALKART.NS's ROE of N/A. Regarding short-term risk, HEALTHX.NS is similarly volatile compared to DENTALKART.NS. This indicates similar risk in terms of short-term price fluctuations for HEALTHX.NS.Check DENTALKART.NS's competition here
PNGS Gargi Fashion Jewellery L (BSE: GARGI.BO)
HEALTHX.NS vs GARGI.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, GARGI.BO has a market cap of 6.3B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while GARGI.BO trades at ₹599.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas GARGI.BO's P/E ratio is 182.62. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to GARGI.BO's ROE of +0.23%. Regarding short-term risk, HEALTHX.NS is more volatile compared to GARGI.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check GARGI.BO's competition here
Khemani Distributors & Marketing Limited (BSE: KDML.BO)
HEALTHX.NS vs KDML.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, KDML.BO has a market cap of 3.1B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while KDML.BO trades at ₹132.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas KDML.BO's P/E ratio is -23.52. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to KDML.BO's ROE of -0.14%. Regarding short-term risk, HEALTHX.NS is more volatile compared to KDML.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check KDML.BO's competition here
Logica Infoway Limited (BSE: LOGICA.BO)
HEALTHX.NS vs LOGICA.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, LOGICA.BO has a market cap of 2.7B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while LOGICA.BO trades at ₹149.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas LOGICA.BO's P/E ratio is 18.72. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to LOGICA.BO's ROE of N/A. Regarding short-term risk, HEALTHX.NS is more volatile compared to LOGICA.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check LOGICA.BO's competition here
Competent Automobiles Company Limited (BSE: COMPEAU.BO)
HEALTHX.NS vs COMPEAU.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, COMPEAU.BO has a market cap of 2.3B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while COMPEAU.BO trades at ₹366.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas COMPEAU.BO's P/E ratio is 9.37. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to COMPEAU.BO's ROE of +0.06%. Regarding short-term risk, HEALTHX.NS is more volatile compared to COMPEAU.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check COMPEAU.BO's competition here
IntraSoft Technologies Limited (NSE: ISFT.NS)
HEALTHX.NS vs ISFT.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, ISFT.NS has a market cap of 1.6B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while ISFT.NS trades at ₹95.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas ISFT.NS's P/E ratio is 11.70. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to ISFT.NS's ROE of +0.05%. Regarding short-term risk, HEALTHX.NS is less volatile compared to ISFT.NS. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check ISFT.NS's competition here
IntraSoft Technologies Limited (BSE: ISFT.BO)
HEALTHX.NS vs ISFT.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, ISFT.BO has a market cap of 1.5B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while ISFT.BO trades at ₹95.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas ISFT.BO's P/E ratio is 11.69. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to ISFT.BO's ROE of +0.05%. Regarding short-term risk, HEALTHX.NS is less volatile compared to ISFT.BO. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check ISFT.BO's competition here
Lloyds Luxuries Ltd. (NSE: LLOYDS.NS)
HEALTHX.NS vs LLOYDS.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, LLOYDS.NS has a market cap of 1.4B. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while LLOYDS.NS trades at ₹57.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas LLOYDS.NS's P/E ratio is -2.04. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to LLOYDS.NS's ROE of N/A. Regarding short-term risk, HEALTHX.NS is more volatile compared to LLOYDS.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check LLOYDS.NS's competition here
Praxis Home Retail Limited (BSE: PRAXIS.BO)
HEALTHX.NS vs PRAXIS.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, PRAXIS.BO has a market cap of 767.7M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while PRAXIS.BO trades at ₹4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas PRAXIS.BO's P/E ratio is -1.36. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to PRAXIS.BO's ROE of +4.81%. Regarding short-term risk, HEALTHX.NS is more volatile compared to PRAXIS.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check PRAXIS.BO's competition here
Praxis Home Retail Limited (NSE: PRAXIS.NS)
HEALTHX.NS vs PRAXIS.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, PRAXIS.NS has a market cap of 760M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while PRAXIS.NS trades at ₹4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas PRAXIS.NS's P/E ratio is -1.34. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to PRAXIS.NS's ROE of +4.81%. Regarding short-term risk, HEALTHX.NS is less volatile compared to PRAXIS.NS. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check PRAXIS.NS's competition here
Womancart Ltd. (NSE: WOMANCART.NS)
HEALTHX.NS vs WOMANCART.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, WOMANCART.NS has a market cap of 747.2M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while WOMANCART.NS trades at ₹106.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas WOMANCART.NS's P/E ratio is 7.55. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to WOMANCART.NS's ROE of N/A. Regarding short-term risk, HEALTHX.NS is more volatile compared to WOMANCART.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check WOMANCART.NS's competition here
Digidrive Distributors Limited (NSE: DIGIDRIVE.NS)
HEALTHX.NS vs DIGIDRIVE.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, DIGIDRIVE.NS has a market cap of 670.5M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while DIGIDRIVE.NS trades at ₹17.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas DIGIDRIVE.NS's P/E ratio is 12.45. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to DIGIDRIVE.NS's ROE of +0.02%. Regarding short-term risk, HEALTHX.NS is more volatile compared to DIGIDRIVE.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check DIGIDRIVE.NS's competition here
Archies Limited (BSE: ARCHIES.BO)
HEALTHX.NS vs ARCHIES.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, ARCHIES.BO has a market cap of 423.8M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while ARCHIES.BO trades at ₹12.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas ARCHIES.BO's P/E ratio is -9.85. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to ARCHIES.BO's ROE of -0.05%. Regarding short-term risk, HEALTHX.NS is more volatile compared to ARCHIES.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check ARCHIES.BO's competition here
Archies Limited (NSE: ARCHIES.NS)
HEALTHX.NS vs ARCHIES.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, ARCHIES.NS has a market cap of 415.2M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while ARCHIES.NS trades at ₹12.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas ARCHIES.NS's P/E ratio is -9.74. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to ARCHIES.NS's ROE of -0.05%. Regarding short-term risk, HEALTHX.NS is more volatile compared to ARCHIES.NS. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check ARCHIES.NS's competition here
Pace E-Commerce Ventures Ltd. (BSE: PACE.BO)
HEALTHX.NS vs PACE.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, PACE.BO has a market cap of 337.6M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while PACE.BO trades at ₹14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas PACE.BO's P/E ratio is 8.97. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to PACE.BO's ROE of +0.05%. Regarding short-term risk, HEALTHX.NS is more volatile compared to PACE.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check PACE.BO's competition here
Haria Exports Limited (BSE: HARIAEXPO.BO)
HEALTHX.NS vs HARIAEXPO.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, HARIAEXPO.BO has a market cap of 112.7M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while HARIAEXPO.BO trades at ₹9.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas HARIAEXPO.BO's P/E ratio is 124.97. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to HARIAEXPO.BO's ROE of +0.00%. Regarding short-term risk, HEALTHX.NS is more volatile compared to HARIAEXPO.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check HARIAEXPO.BO's competition here
Shashank Traders Limited (BSE: SHASHANK.BO)
HEALTHX.NS vs SHASHANK.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, SHASHANK.BO has a market cap of 105.3M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while SHASHANK.BO trades at ₹34.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas SHASHANK.BO's P/E ratio is -47.29. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to SHASHANK.BO's ROE of N/A. Regarding short-term risk, HEALTHX.NS is more volatile compared to SHASHANK.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check SHASHANK.BO's competition here
Deep Diamond India Limited (BSE: DDIL.BO)
HEALTHX.NS vs DDIL.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, DDIL.BO has a market cap of 95.1M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while DDIL.BO trades at ₹1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas DDIL.BO's P/E ratio is 4.42. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to DDIL.BO's ROE of +0.26%. Regarding short-term risk, HEALTHX.NS is more volatile compared to DDIL.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check DDIL.BO's competition here
Rajputana Investment and Finan (BSE: RAJPUTANA.BO)
HEALTHX.NS vs RAJPUTANA.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, RAJPUTANA.BO has a market cap of 92.6M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while RAJPUTANA.BO trades at ₹30.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas RAJPUTANA.BO's P/E ratio is 231.38. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to RAJPUTANA.BO's ROE of +0.02%. Regarding short-term risk, HEALTHX.NS is more volatile compared to RAJPUTANA.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check RAJPUTANA.BO's competition here
U. H. Zaveri Ltd. (BSE: UHZAVERI.BO)
HEALTHX.NS vs UHZAVERI.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, UHZAVERI.BO has a market cap of 84.8M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while UHZAVERI.BO trades at ₹8.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas UHZAVERI.BO's P/E ratio is 425.50. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to UHZAVERI.BO's ROE of +0.00%. Regarding short-term risk, HEALTHX.NS is less volatile compared to UHZAVERI.BO. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check UHZAVERI.BO's competition here
Veerkrupa Jewellers Limited (BSE: VEERKRUPA.BO)
HEALTHX.NS vs VEERKRUPA.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, VEERKRUPA.BO has a market cap of 62.9M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while VEERKRUPA.BO trades at ₹0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas VEERKRUPA.BO's P/E ratio is 48.00. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to VEERKRUPA.BO's ROE of +0.02%. Regarding short-term risk, HEALTHX.NS is more volatile compared to VEERKRUPA.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check VEERKRUPA.BO's competition here
Spectra Industries Limited (BSE: SPECTRA.BO)
HEALTHX.NS vs SPECTRA.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, SPECTRA.BO has a market cap of 27.5M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while SPECTRA.BO trades at ₹3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas SPECTRA.BO's P/E ratio is -1.35. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to SPECTRA.BO's ROE of +0.07%. Regarding short-term risk, HEALTHX.NS is less volatile compared to SPECTRA.BO. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check SPECTRA.BO's competition here
JLA Infraville Shoppers Limited (BSE: JSHL.BO)
HEALTHX.NS vs JSHL.BO Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, JSHL.BO has a market cap of 14M. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while JSHL.BO trades at ₹2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas JSHL.BO's P/E ratio is -3.16. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to JSHL.BO's ROE of -0.06%. Regarding short-term risk, HEALTHX.NS is more volatile compared to JSHL.BO. This indicates higher risk in terms of short-term price fluctuations for HEALTHX.NS.Check JSHL.BO's competition here
Praxis Home Retail Ltd. (NSE: PRAXIS-RE.NS)
HEALTHX.NS vs PRAXIS-RE.NS Comparison September 2026
Health X Platform Ltd (NSE: HEALTHX.NS) plays a significant role within the Consumer Cyclical sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEALTHX.NS stands at 9.5B. In comparison, PRAXIS-RE.NS has a market cap of 0. Regarding current trading prices, HEALTHX.NS is priced at ₹300.00 on the NSE, while PRAXIS-RE.NS trades at ₹15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEALTHX.NS currently has a P/E ratio of 810.81, whereas PRAXIS-RE.NS's P/E ratio is N/A. In terms of profitability, HEALTHX.NS's ROE is N/A, compared to PRAXIS-RE.NS's ROE of N/A. Regarding short-term risk, HEALTHX.NS is less volatile compared to PRAXIS-RE.NS. This indicates lower risk in terms of short-term price fluctuations for HEALTHX.NS.Check PRAXIS-RE.NS's competition here